Press release
Overactive Bladder Treatment (OAB) Market worth $4.2 Billion by 2027 - Leading Key Players are Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (US), Medtronic Plc (Ireland), AbbVie Inc. (US)
Overactive Bladder Treatment (OAB) Market
Browse in-depth TOC on "Overactive Bladder Treatment (OAB) Market"
156 - Tables
48 - Figures
198 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219938791&utm_source=openpr&utm_medium=referral
The Increasing number of patients undergoing neuromodulation coupled with launch of novel drugs is likely to drive the growth of market. Rising number of patient with overactive bladder coupled with increasing awareness among the developing countries is anticipated to increase demand for treatment options in coming years, this factor is expected to upsurge the growth during the forecast period.
The others segment is estimated to grow with highest CAGR during the forecast period of overactive bladder treatment market
Based on type, the overactive bladder treatment market is segmented into anticholinergics, mirabegron, BOTOX, neuromodulation, and other treatments. Other treatment segment is expected to grow at faster pace owing to launch of several novel drugs in the pipeline. For instance, Urovant Sciences' URO-902, is a novel gene therapy for patients with overactive bladder (OAB) symptoms currently under Phase 2 clinical trials.
The Idiopathic OAB is registered to grow at faster pace during the forecast period of 2022-2027.
Based on disease type, the overactive bladder treatment market is segmented into idiopathic overactive bladder & neurogenic overactive bladder. Rising aging population is one of the factor increasing number of patients suffering from idiopathic overactive bladder hence projecting the growth of the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219938791&utm_source=openpr&utm_medium=referral
North America has registered fastest growth rate during the forecast period in overactive bladder treatment market
The global overactive bladder treatments market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is anticipated to grow at faster pace owing to favorable reimbursement policies and increased demand for treatment in the region.
The overactive bladder treatment market is fragmented in nature with prominent players operating in this market such as are Astellas Pharma (Japan), Teva Pharmaceutical Industries (Israel), Pfizer (US), Medtronic (Ireland), AbbVie (US), Viatris (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson Services (US), Endo Pharmaceuticals Lupin (India) , Amneal Pharmaceuticals (US), Sun Pharmaceutical Industries (India) and among others.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=219938791&utm_source=openpr&utm_medium=referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overactive Bladder Treatment (OAB) Market worth $4.2 Billion by 2027 - Leading Key Players are Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (US), Medtronic Plc (Ireland), AbbVie Inc. (US) here
News-ID: 2687485 • Views: …
More Releases from MarketsandMarkets™.
Bone Growth Stimulator Market worth $1.8 billion by 2027 - Leading Key Players a …
- Bone Growth Stimulator Market is projected to grow from USD 1.4 billion in 2022 to USD 1.8 billion by 2027, at a CAGR of 5.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the global bone growth stimulators market can be attributed to factors such as increasing research activities for the development of novel bone growth stimulators devices, growing demand for bone growth…
Protein Expression Market worth $5.4 billion by 2027 - Exclusive Report by Marke …
Protein Expression Market is projected to grow from USD 2.9 billion in 2022 to USD 5.4 billion by 2027, at a CAGR of 13.3% from 2022 to 2027, according to a study published by MarketsandMarkets™. The Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research.…
OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by …
The OTC Braces and Supports Market is valued at an estimated USD 942 million in 2022 and is projected to reach USD 1,286 million by 2027, at a CAGR of 6.4%, according to a new report by MarketsandMarkets™. Market growth is driven by the rising technological advancements in OTC braces and supports, increasing orthopedic disorders and the growing awareness of preventive diagnosis in developing countries. Emerging economies such as China,…
Artificial Intelligence (AI) in Medical Diagnostics Market worth $5.5 billion by …
Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow from USD 1.0 billion in 2022 to USD 5.5 billion by 2027, at a CAGR of 39.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The application of AI in medical diagnostics is growing at a fast pace owing to factors such as growing government initiatives to drive the adoption of AI-based technologies, rise in adoption…
More Releases for OAB
OAB Treatment Market Outlook and Future Projections for 2030
The oab treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Overactive Bladder OAB Therapeutics Market Size to Touch USD 3577.78 million by …
The report on Global Overactive Bladder OAB Therapeutics Market is a comprehensive exploration offering growth rate, size of the industry, competitive landscape information, factors contributing growth of the market and more.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5668968/
…
Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women.
The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking.
The most common symptoms…
Overactive Bladder (OAB) Therapeutics Market to Witness Huge Growth by 2028 | Te …
Understanding customer behavior towards particular product or service and target audience plays vital role to strengthen the position in the marketplace. This Overactive Bladder (OAB) Therapeutics market analysis sheds light on key points and measures to follow for business growth. It focuses on a wide array of business facets including pillars, planning models, sales strategies and features. It also covers principal data related to major players, their adopted strategies, competitive…
Overactive Bladder (OAB) Treatment- Global Market Outlook 2019-2024
Global Overactive Bladder Treatment Market, delivering a must-read report for industry stakeholders wanting to understand the strategic landscape of this burgeoning sector. Readers will find an in-depth analysis of the market and how it will impact existing traditional markets, as well as insights into future development and opportunities across the globe.
MarketInsightsReports has announced the addition of the "Global Overactive Bladder Treatment Market Research Report 2018" The report focuses on global…
Global OAB Treatment Market Growth (Status and Outlook) 2019-2024
LP INFORMATION offers a latest published report on OAB Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the OAB Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
